Initial Pre-Emergency Use Authorization submission made to U.S. FDA for use of ReCell^® in a Mass Casualty Scenario

July 29, 2026

Stay Up to Date

Sign up now to receive updates through our newsletter regarding new research and more.

Related Resources

May 5, 2026

Overcome Allograft Challenges with a Biosynthetic Wound Matrix
Read more: Overcome Allograft Challenges with a Biosynthetic Wound Matrix
February 2, 2026

Moist Wound Healing and the Practical Role of Temporary Biosynthetic Wound Matrix in Acute Care
Read more: Moist Wound Healing and the Practical Role of Temporary Biosynthetic Wound Matrix in Acute Care
January 26, 2026

Dermal Matrices: What Features Matter Most For Time To Graft?
Read more: Dermal Matrices: What Features Matter Most For Time To Graft?